Biodesix outlines $106M-$112M 2026 revenue target as sales expansion drives 41% Q4 growth
Source: SeekingAlpha
2026-02-26 21:18:35 ET
More on Biodesix
- Biodesix, Inc. (BDSX) Q4 2025 Earnings Call Transcript
- Biodesix skyrockets 43%, expects FY revenue to beat guidance
- Seeking Alpha’s Quant Rating on Biodesix
- Historical earnings data for Biodesix
- Financial information for Biodesix
Read the full article on Seeking Alpha
For further details see:
Biodesix outlines $106M–$112M 2026 revenue target as sales expansion drives 41% Q4 growth
Biodesix Inc.
NASDAQ: BDSX
BDSX Trading
5.68% G/L:
$18.69 Last:
51,874 Volume:
$18.61 Open:
BDSX Latest News
February 26, 2026 04:01:00 pm
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
BDSX Stock Data
$83,296,022
3,850,552
19.65%
10
N/A
Medical Diagnostics & Screening
Healthcare
US
Louisville
